Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NovoSeven Secondary Prophylaxis in Hemophilia with Inhibitors
NCT00108758Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Mar 2004
- Primary completion
- Nov 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 12
01
Overview
A Phase 2 trial of coagulation factor VIIa in hemophilia A, hemophilia B (HB), sponsored by Novo Nordisk. Started Mar 2004; status: completed.
02
Drugs
coagulation factor VIIa
03
Conditions
hemophilia Ahemophilia B (HB)
Beyond the preview
Go deeper on NCT00108758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00108758.